ch.oddb.org
 
Analysen | Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Ramipril Sandoz®:Sandoz Pharmaceuticals AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
C09AA05 - RamiprilATC-DDD Version 2016. Source: WHO
C - Cardiovascular System
 
C09 - Agents Acting on The Renin-Angiotensin System
 

The DDDs are based on the treatment of mild-moderate hypertension.
See comments to C02L concerning the principles for assignment of DDDs for combined preparations.

C09A - Ace Inhibitors, plain

All plain ACE inhibitors are classified in this group. No separate ATC codes are assigned for the esters of the ACE inhibitors (e.g. enalaprilat, quinaprilat).
Combinations with diuretics, see C09BA - ACE inhibitors and diuretics.
Combinations with calcium channel blockers, see C09BB - ACE inhibitors and calcium channel blockers.
Combinations with beta blocking agents, see C09BX - ACE inhibitors, other combinations.

C09AA - Ace Inhibitors, plain
 
C09AA05 - Ramipril
StärkeAdm.RouteNote
2.5 mgO 
2018 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home